5 August 2017 in Annals of Neurology
1 October 2019 in Clinical Neurophysiology
1 January 2005 in Journal of Psychophysiology
Performance monitoring represents a critical executive function of the human brain. In an effort to identify its anatomical and physiological aspects, a negative component of event-related potentials (ERPs), which occurs only on incorrect trials, has been used in the extensive investigation of error processing. This component has been termed “error-negativity” (Ne) or error-related negativity (ERN) and has been interpreted as a correlate of error detection. The aim of the present intracerebral ERP study was to contribute knowledge of the sources of the Ne/ERN, with a particular focus on the involvement of a frontomedian wall (FMW) in the genesis of this negativity. Seven patients with intractable epilepsy participated in the study. Depth electrodes were implanted to localize the seizure origin prior to surgical treatment. A total of 574 sites in the frontal, temporal, and parietal lobes were investigated. A simple Go/NoGo task was performed and EEG epochs with correct and erroneous motor responses were averaged independently using the response as the trigger. Ne/ERN was generated in multiple cortical structures, with the most consistent involvement being that of the FMW structures. Ne/ERN generators were revealed there in both the rostral and caudal anterior cingulate cortex (ACC), but also in the pre-SMA and in the parts of the medial frontal gyrus adjacent to the ACC. Different timing of activations between the rostral and caudal anterior cingulate Ne/ERN sources was observed in this study. Other neural sources of the Ne/ERN were found in the dorsolateral prefrontal cortex, in the orbitofrontal cortex, in the lateral temporal neocortex, and in one isolated case in the supramarginal gyrus. Our findings support the key role of the FMW in the genesis of Ne/ERN. At the same time, our findings suggest a different functional significance for the rostral and caudal ACC involvement in error processing. In addition to the FMW, the other prefrontal cortical sites, the lateral temporal neocortex, and the supramarginal gyrus seem to represent integral components of the brain's error monitoring system.
10 September 2002 in Experimental Brain Research
1 August 2003 in Clinical Neurophysiology
2 May 2019 in Frontiers in Neurology
Background: Chronic vagal nerve stimulation (VNS) is a well-established non-pharmacological treatment option for drug-resistant epilepsy. This study sought to develop a statistical model for prediction of VNS efficacy. We hypothesized that reactivity of the electroencephalogram (EEG) to external stimuli measured during routine preoperative evaluation differs between VNS responders and non-responders. Materials and Methods: Power spectral analyses were computed retrospectively on pre-operative EEG recordings from 60 epileptic patients with VNS. Thirty five responders and 25 non-responders were compared on the relative power values in four standard frequency bands and eight conditions of clinical assessment—eyes opening/closing, photic stimulation, and hyperventilation. Using logistic regression, groups of electrodes within anatomical areas identified as maximally discriminative by n leave-one-out iterations were used to classify patients. The reliability of the predictive model was verified with an independent data-set from 22 additional patients. Results: Power spectral analyses revealed significant differences in EEG reactivity between responders and non-responders; specifically, the dynamics of alpha and gamma activity strongly reflected VNS efficacy. Using individual EEG reactivity to develop and validate a predictive model, we discriminated between responders and non-responders with 86% accuracy, 83% sensitivity, and 90% specificity. Conclusion: We present a new statistical model with which EEG reactivity to external stimuli during routine presurgical evaluation can be seen as a promising avenue for the identification of patients with favorable VNS outcome. This novel method for the prediction of VNS efficacy might represent a breakthrough in the management of drug-resistant epilepsy, with wide-reaching medical and economic implications.